| Authors: |
de Breuk A; Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands., de Jong S; Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands., Bakker B; Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands., Kersten E; Department of Ophthalmology, Rijnstate, Arnhem, The Netherlands., Luttikhuizen DT; Department of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands.; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands., Fauser S; Department of Ophthalmology, University Hospital of Cologne, Cologne, Germany.; Roche Pharma Research and Early Development, F. Hoffmann-La Roche, Basel, Switzerland., Klaver CCW; Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands.; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.; Institute of Molecular and Clinical Ophthalmology, Basel, Switzerland., den Hollander AI; Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands.; Ophthalmology Research, Sanofi, Cambridge, Massachusetts., Hoyng CB; Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands., Lechanteur YTE; Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands. |
